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A B S T R A C T   
The behavioral immune system is considered to be a psychological adaptation that decreases the risk of infection. 
Research suggests that, in the current environment, this system can produce attitudes with negative health 
consequences, such as increased vaccine hesitancy. In three studies, we investigated whether two facets of the 
behavioral immune system—germ aversion (i.e., aversion to potential pathogen transmission) and perceived 
infectability (i.e., perceived susceptibility to disease)—predicted intentions to accept COVID-19 and influenza 
vaccination during the pandemic. The behavioral immune system mechanisms were measured before the COVID- 
19 pandemic in one study, and during the pandemic in two. In contrast to previous research, those with higher 
germ aversion during the pandemic perceived vaccines to be safer and had higher intentions to accept vacci-
nation. Germ aversion before the pandemic was not associated with vaccination intentions. Individuals who 
perceived themselves as more susceptible to disease were slightly more willing to accept vaccination. We 
conjecture that high disease threat reverses the relationship between the behavioral immune system response 
and vaccination. As the associations were weak, individual differences in germ aversion and perceived infect-
ability are of little practical relevance for vaccine uptake.   
1. Introduction 
Less than one year from the pandemic outbreak, safe and effective 
vaccines against the SARS-CoV-2 virus started to become available. 
Although some of these vaccines have efficacies in excess of 90% (Baden 
et al., 2021; Polack et al., 2020), successful suppression of the pandemic 
ultimately depends on the public’s acceptance of the vaccines. Research 
surveying acceptance rates before COVID-19 vaccinations began indi-
cated that 5–26% of individuals in European countries intended to 
refuse vaccination, and an additional 12–28% were unsure about their 
vaccination decision (Detoc et al., 2020; Freeman et al., 2020; 
Neumann-Böhme et al., 2020; The COCONEL Group, 2020; Ward, 
Alleaume, Peretti-Watel, & the COCONEL Group, 2020). In the US and 
Canada, 14–25% indicated that they would refuse a COVID-19 vacci-
nation (Reiter, Pennell, & Katz, 2020; Taylor et al., 2020), whereas 7% 
of individuals in Australia reported that they would definitely or prob-
ably not accept a COVID-19 vaccine (Faasse & Newby, 2020). 
Deciding whether to take a vaccine is a complex psychological pro-
cess driven by several factors. Research has demonstrated that attitudes 
towards the vaccine-preventable disease, as well as beliefs regarding the 
safety and effectiveness of the vaccines, play a key role in explaining 
vaccine hesitancy (Betsch et al., 2018; Brewer, Chapman, Rothman, 
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Leask, & Kempe, 2017; Larson, Jarrett, Eckersberger, Smith, & Paterson, 
2014; Thomson, Robinson, & Vallée-Tourangeau, 2016). This means 
that understanding the psychology behind these driving attitudes is of 
considerable importance for ensuring sufficient uptake of COVID-19 
vaccines. In the present study, we investigated the degree to which 
dispositional differences related to psychological disease-avoidance 
mechanisms—the behavioral immune system—explain people’s in-
tentions to accept a COVID-19 vaccine as well as their concerns 
regarding its safety. The behavioral immune system includes cognitive, 
emotional, and behavioral mechanisms that during our evolutionary 
history have decreased the risk of infection. 
1.1. Mechanisms of the behavioral immune system 
The detrimental effects of infectious diseases on survival are assumed 
to have resulted in the selection of psychological mechanisms, across 
evolutionary time scales, that decreased the risk of pathogenic 
contamination. These psychological adaptations include cognitive, 
emotional, and behavioral mechanisms that have been labeled the 
behavioral immune system (Schaller, 2006; Schaller & Park, 2011). The 
behavioral immune system evolved to identify potential sources of 
pathogens in the environment and to motivate behaviors that decrease 
the risk of pathogen exposure. An emotion that is central to the 
behavioral immune system is disgust (Curtis, Barra, & Aunger, 2011; 
Oaten, Stevenson, & Case, 2009; Schaller & Park, 2011; Tybur, Lieber-
man, Kurzban, & DeScioli, 2013). Disgust motivates avoidance of 
sources identified as potentially containing pathogens. As most patho-
gens cannot be directly observed, the behavioral immune system re-
sponds to environmental cues that in our past correlated with the 
presence of pathogens. Examples of such cues include spoiled food, the 
smell of biological decay, bodily secretions (e.g., saliva, nasal secretion, 
mucus), and wounds (Oaten et al., 2009). Because pathogen cues are not 
perfectly correlated with the actual presence of pathogens, the system 
might erroneously activate when pathogens are not present or fail to 
activate when pathogens are present. As failing to react to existing 
pathogens tends to have more detrimental consequences than reacting 
in their absence, the system evolved to be hypersensitive (Ackerman, 
Hill, & Murray, 2018; Schaller & Park, 2011). The behavioral immune 
system therefore occasionally responds to cues that pose no actual 
infection threat. This hypersensitivity leads us to avoid healthy and 
nutritious food sources that smell like spoiled food (e.g., fermented fish, 
aged cheese) or avoid social contact with individuals who have de-
formities that are not contagious. 
Avoiding potential sources of pathogens comes with both benefits (e. 
g., successful avoidance of contaminated food) and costs (e.g., missed 
opportunity to get nutrition). The cost-benefit ratio is a trade-off that the 
individual must balance. The optimal ratio depends on how vulnerable 
the individual is to infection, and, therefore, the behavioral immune 
system is assumed to be flexible. This means that when individuals 
perceive the situation to have high contamination risk, and perceive 
themselves to be more vulnerable, they are expected to be more atten-
tive to pathogen cues and react more strongly to them than when risk 
and vulnerability is judged to be low (Ackerman et al., 2018; Schaller & 
Park, 2011). 
1.2. The behavioral immune system and vaccination 
The behavioral immune system has been found to be related to a 
wide range of attitudes and behaviors humans display in the modern 
environment. Unsurprisingly, the behavioral immune system has been 
shown to be involved in attitudes and behaviors that promote health 
(Gruijters, Tybur, Ruiter, & Massar, 2016; Murray & Schaller, 2016; 
Schaller, Murray, & Bangerter, 2015). However, the behavioral immune 
response may also have negative health consequences. For example, as 
many infectious diseases are transmitted through interpersonal contact, 
considering oneself vulnerable to infection may lead to reduced 
sociability (Murray & Schaller, 2016; Schaller et al., 2015). At the same 
time, social isolation and loneliness is associated with long-term, 
negative health outcomes (Hawkley & Cacioppo, 2010; Hawkley & 
Capitanio, 2015; Jaremka et al., 2013). 
Another area where the behavioral immune response might have 
negative health consequences is in making decisions about vaccination. 
Because the purpose of vaccination is to protect against infectious dis-
eases, individuals with higher propensity to experience disgust towards 
potential sources of pathogens (hereafter, pathogen disgust sensitivity) 
and who react more negatively to potential pathogen transmission 
(hereafter, germ aversion) could be expected to have more positive at-
titudes towards vaccination. Seemingly paradoxically, several studies 
show that individuals with higher pathogen disgust sensitivity and more 
germ aversion hold more negative vaccine attitudes (Clay, 2017; Clif-
ford & Wendell, 2016; Luz, Brown, & Struchiner, 2019; Reuben, Aitken, 
Freedman, & Einstein, 2020). Luz et al. (2019) further investigated 
whether pathogen disgust sensitivity and germ aversion were related to 
past uptake of the influenza vaccine. They found a relationship between 
lower likelihood of having accepted the vaccine and higher pathogen 
disgust sensitivity and germ aversion that was mediated by more 
negative vaccine attitudes. In addition, there was a positive direct 
relationship between pathogen disgust sensitivity and vaccine uptake, 
indicating that those with higher propensity to experience pathogen 
disgust were more likely to have been vaccinated, when controlling for 
vaccine attitudes. This could indicate that pathogen disgust sensitivity 
and germ aversion negatively affect vaccine uptake only to the degree 
that it affects vaccine attitudes. 
A proposed explanation for the surprising result that those with high 
pathogen disgust sensitivity and germ aversion have more negative 
vaccine attitudes is that vaccines are administered in ways that in and by 
themselves are cues to contamination, such as puncturing the skin, and 
inhalation or ingestion of a foreign substance (Clay, 2017). For this 
explanation to be supported, individuals who are more averse to path-
ogens and contamination should react to vaccination as a contamination 
cue. This reaction would, in turn, lead to more negative attitudes to-
wards vaccines. This notion derives support from the finding that in-
dividuals with higher disgust towards needles and blood hold more 
negative attitudes to the safety and efficacy of vaccinations (Hornsey 
et al., 2018a). Individuals with injection fears have also been found less 
willing to accept vaccination against COVID-19 (Freeman et al., 2021). 
Furthermore, vaccination opponents commonly describe vaccines as 
‘unnatural’, containing toxic substances, and causing illness (Kata, 
2010; Moran, Lucas, Everhart, Morgan, & Prickett, 2016). Concerns 
about vaccine safety has been found to be among the most common 
reasons for unwillingness to accept COVID-19 vaccination (Karlsson 
et al., 2021; Neumann-Böhme et al., 2020; Taylor et al., 2020). In this 
manner, higher germ aversion could, ironically, increase reluctance to 
take a vaccine against COVID-19. 
The theory of the behavioral immune system also suggests that 
perceiving oneself as particularly susceptible to infectious diseases 
(hereafter, perceived infectability) should further promote behaviors 
that protect against disease. Research on the association between 
perceived infectability and vaccination has produced somewhat con-
flicting results. Although some studies show that perceived infectability 
is unrelated to vaccine attitudes (Clay, 2017; Luz et al., 2019), the 
likelihood of accepting the influenza vaccine has been shown to be 
higher in individuals with higher perceived infectability (Luz et al., 
2019). Taken together, this indicates that perceiving oneself at a higher 
risk of catching infections might motivate people to get vaccinated 
regardless of their vaccine attitudes. 
1.3. The behavioral immune system and the COVID-19 pandemic 
As mentioned above, the theory of the behavioral immune system 
stipulates that situational factors, such as the degree of disease threat, 
should affect the aversive response (Ackerman et al., 2018; Oaten et al., 
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2009). The hypothesized effect of increased disease threat on behavioral 
immune system activation has, however, been investigated only in a few 
studies. A study in an Australian sample of university students surveyed 
during the lockdown in spring 2020 found higher disgust sensitivity and 
germ aversion than in comparable samples collected before the COVID- 
19 pandemic (Stevenson, Saluja, & Case, 2021). There was no difference 
in perceived infectability between the pre- and mid-pandemic samples. 
Studies also indicate that individuals with higher pathogen disgust 
sensitivity and germ aversion react more strongly to the pandemic 
threat, as they consider government measures more necessary, find it 
more important to engage in preventive behaviors such as handwashing 
and social distancing, and report higher compliance with recommen-
dations (De Coninck, D’Haenens, & Matthijs, 2020; Díaz & Cova, 2020; 
Makhanova & Shepherd, 2020; Shook, Sevi, Lee, Oosterhoff, & Fitz-
gerald, 2020). In contrast to vaccination, these non-pharmaceutical in-
terventions and behaviors include no contamination cues. 
Previous research on the behavioral immune system and vaccination 
has been conducted before the pandemic, during lower disease threat. 
We know of no previous studies that have investigated if people’s will-
ingness to take the COVID-19 vaccine—a higher disease-threat sit-
uation—is related to the behavioral immune system. If there is a 
relationship between germ aversion, perceived infectability, and 
COVID-19 vaccination intentions, this information can be used when 
developing efficient health-communication strategies. 
1.4. The current study 
We examined the relationship between the behavioral immune sys-
tem and intentions to accept vaccination against COVID-19 and per-
ceptions about the safety of a COVID-19 vaccine. More specifically, we 
investigated whether germ aversion and perceived infectability pre-
dicted vaccination intentions and vaccine safety perceptions in three 
studies in Finland. Based on the previous literature, we predicted that 1) 
individuals with more (vs. less) germ aversion would have lower 
vaccination intentions, that 2) individuals with more (vs. less) germ 
aversion would perceive vaccines as less safe, and that 3) individuals 
with high (vs. low) perceived infectability would have higher vaccina-
tion intentions. Previous research on the topic has investigated general 
vaccine attitudes and attitudes towards childhood vaccines (Clay, 2017; 
Clifford & Wendell, 2016; Hornsey et al., 2018b; Luz et al., 2019; 
Reuben et al., 2020) and past influenza vaccinations (Luz et al., 2019). 
To facilitate comparison with previous research, we also measured in-
tentions to get vaccinated against influenza. In Finland, the influenza 
vaccines are administered free of charge to risk groups (e.g., older in-
dividuals and young children) and health professionals (Finnish Institute 
for Health and Welfare, 2021b). Some employers also offer free influ-
enza vaccinations to their employees. In other cases, individuals are 
required to cover the costs themselves. 
Study 1 was longitudinal and conducted in a sample of parents of 
young children. We measured the parents’ germ aversion and perceived 
infectability before the pandemic outbreak, in 2018, and their vacci-
nation intentions after the first peak of the coronavirus pandemic in 
Finland in 2020 (between May 4th and June 7th). By this time, the 
weekly incidence of COVID-19 cases per 100,000 inhabitants decreased 
from ~11 (calendar week 19) to ~3 (calendar week 23). Studies 2 and 3 
were cross-sectional and carried out during the peak of the first 
pandemic wave in Finland (Study 2 between March 30th and April 12th, 
2020, and Study 3 between April 3rd and 17th, 2020). During this time, 
the weekly incidence of COVID-19 cases was ~16 per 100,000 in-
habitants. In Study 2, we surveyed people living in an area with sub-
optimal uptake of vaccines included in the national vaccination 
program, and, in Study 3, we surveyed a national sample of Facebook 
users. 
To receive an estimate of the overall size of the associations between 
the behavioral immune system mechanisms and vaccination intentions, 
we combined the effect sizes obtained using meta-analysis. 
2. Study 1: method 
2.1. Respondents and procedure 
We sourced respondents from the FinnBrain Birth Cohort Study (L. 
Karlsson et al., 2018). The FinnBrain study is a longitudinal project that 
investigates child development by collecting information from children 
and their parents in the Turku region and on the Åland islands. In May 
2018, we invited all parents with at least one child younger than 
4.5 years (N = 3401) to an online survey to investigate vaccination at-
titudes and behaviors. The survey included measures of behavioral im-
mune system mechanisms. A total of 761 (22.4%) responded to the 
survey. In May 2020, all parents participating in the FinnBrain study 
(N = 5103) were invited to a survey concerning the coronavirus 
pandemic, which included measures of vaccination intentions. The 
survey was open for five weeks, and 856 (16.8%) parents responded. In 
the present study, we included the 294 parents who responded at both 
time points. The mean age of the sample was 38.09 years (SD = 4.76, 
range = 24–55; see Table 1 for descriptive statistics). We conducted 
comparisons between those individuals who responded to both time-
points and those who responded only in 2018 with regard to de-
mographic variables, germ aversion, and perceived infectability. The 
results from these analyses are reported in the online supplementary 
material. 
Ethical approval for both data collections was obtained from the 
Ethics Committee of the Hospital District of Southwest Finland. The 
respondents gave their informed consent in the electronic survey. They 
did not receive any compensation for participation. 
2.2. Measures 
We administered the surveys in either Finnish or Swedish (the two 
official main languages in Finland) depending on the preference of the 
respondent. 
2.2.1. Germ aversion and perceived infectability 
In the 2018 data collection, we administered the Perceived Vulner-
ability to Disease (PVD) scale (Duncan, Schaller, & Park, 2009). The 
scale consists of 15-items divided into two subscales. One subscale 
(Germ aversion; 8 items) measures aversive response in relation to 
Table 1 
Description of the three included samples.  
Variable Study 1 
(N = 294) 
Study 2 
(N = 200) 
Study 3 
(N = 1324) 
n % n % n % 
Agea       
18–29 8 2.72 34 17.09  101  9.88 
30–39 183 62.24 61 30.65  185  18.10 
40–49 100 34.01 44 22.11  255  24.95 
50–59 3 1.02 29 14.57  274  26.81 
60–69 0 0.00 31 15.58  166  16.24 
70+ 0 0.00 0 0.00  41  4.01 
Sexb       
Female 233 79.25 136 68.00  1053  79.59 
Male 61 20.75 63 31.50  253  19.12 
Other – – – –  7  0.53 
Do not want to report – – 1 0.50  10  0.76 
Languageb       
Finnish 245 83.33 34 17.00  1181  89.27 
Swedish 49 16.67 166 83.00  142  10.73 
Note. In Studies 1 and 3, we had information about the respondents’ exact age in 
2020. In Study 2, the respondents indicated the age range they belonged to in the 
2019 data collection. A dash (–) indicates that the response alternative was not 
available. 
a Information about one (0.5%) respondent missing in Study 2, and 302 
(22.8%) in Study 3. 
b Information about one (0.01%) respondent missing in Study 3. 
L.C. Karlsson et al.                                                                                                                                                                                                                             
Personality and Individual Differences 185 (2022) 111295
4
potential pathogen transmission (e.g., “I prefer to wash my hands pretty 
soon after shaking someone’s hand”). The other subscale (Perceived 
infectability; 7 items) measures perceived susceptibility to infectious 
diseases in general (e.g., “I am more likely than the people around me to 
catch an infectious disease”). Item 15 (“I avoid using public telephones 
because of the risk that I may catch something from the previous user”), 
belonging to the subscale Germ aversion, was not administered due to 
the absence of public telephones in Finland. Respondents indicated how 
much they agreed with each statement on a scale from 1 (strongly 
disagree) to 7 (strongly agree). The scale was translated from English to 
Swedish by the authors of the present study (LCK, AS, JA). A professional 
translator then translated the Swedish version of the measure to Finnish. 
Translations were checked and discussed between authors. 
2.2.2. Vaccination intentions 
In the data collection in 2020, we measured intentions to accept a 
vaccine against COVID-19 with the question “How likely do you 
consider it to be that you would take a vaccine against COVID-19, if such 
a vaccine was available, free of charge, and recommended to everyone 
by the authorities?”. We also measured intentions to accept the influ-
enza vaccine for oneself with the question “How likely do you consider it 
to be that you will take the influenza vaccine next season (season 
2020–2021)?”. The respondents answered on a scale from 1 (very un-
likely) to 5 (very likely). 
2.3. Statistical analyses 
We conducted a structural regression (SR) with the package lavaan 
(Rosseel, 2012) in R version 3.5.1 (R Core Team, 2018a, b) to investigate 
whether the PVD subscales measured in 2018 predicted vaccination 
intentions in 2020. The reliability of the two PVD subscales were 
Cronbach’s α = 0.68, 95% CI [0.61, 0.73] and Cronbach’s α = 0.86, 95% 
CI [0.82, 0.89] for germ aversion and perceived infectability, respec-
tively. To account for measurement error, germ aversion and perceived 
infectability were represented by latent factors (see Appendix Table A1 
for the measurement model) in the analyses. The factors were specified 
to predict the two vaccination intention variables. We applied WLSMV 
estimation (factor indicators were specified as ordinal) with delta 
parameterization. Missing data was deleted pairwise. We also conducted 
control analyses including gender and age as covariates. 
3. Study 1: results and discussion 
Information on the parents’ vaccination intentions are presented in 
Table 2 (vaccination intentions of the total 2020 sample are reported in 
the study by LC Karlsson et al., 2021, that investigated the relationship 
between risk perceptions and vaccination intentions using the same 
data-collections as presented here). Information on the parents’ re-
sponses to the PVD scale is presented in Table A2. Zero-order correla-
tions are shown in Table 3. 
The fit of the SR model was good, χ2(97) = 137.78, CFI = 0.990, 
TLI = 0.988, RMSEA = 0.038; 90% CI [0.022, 0.052], SRMR = 0.059. 
Neither germ aversion, nor perceived infectability significantly pre-
dicted intentions to accept a COVID-19 vaccine (Fig. 1; see also, Fig. 5 in 
the Meta-analysis section). Concerning the influenza vaccine, perceived 
infectability was a statistically significant predictor of vaccination in-
tentions. Respondents who consider themselves more vulnerable to in-
fections were more likely to intend to take the influenza vaccine the next 
season. This relationship was, however, weak. Germ aversion did not 
predict influenza vaccination intentions. Including gender and age as 
covariates resulted in the same conclusions (see, Table S1 in the online 
supplementary material). 
The results thus suggested that individuals with higher pre-pandemic 
germ aversion were slightly less willing to accept COVID-19 vaccination, 
but this relationship was not statistically significant. This was the case 
also for seasonal influenza. In contrast to the present study, previous 
research has investigated attitudes and not intentions (Clay, 2017; 
Clifford & Wendell, 2016; Reuben et al., 2020). In the study that found a 
relationship between germ aversion and past influenza vaccination 
behavior (Luz et al., 2019), the relationship was mediated by attitudes to 
vaccines. Potentially, aversive reactions to pathogens and contamina-
tion might co-vary with environmental threat (Ackerman et al., 2018; 
Oaten et al., 2009; Stevenson et al., 2021), and aversion measured in a 
lower threat context is thus a poor predictor of outcomes at higher 
threat. 
Perceiving oneself more susceptible to infectious diseases was not 
significantly related to intentions to accept a COVID-19 vaccine, but 
individuals perceiving themselves as more susceptible to disease re-
ported higher intentions to accept influenza vaccination the next season. 
Speculatively, an explanation for this could be that fewer individuals in 
Finland have suffered from COVID-19 compared to influenza. The re-
spondents’ history of catching influenza or influenza-like illnesses could 
thus play a bigger role in shaping their perceived infectability. 
4. Study 2: method 
In Study 2, we measured the same constructs as in Study 1. The PVD 
scale was administered in 2020 during the pandemic. In addition, we 
measured the respondents’ willingness to accept a test-phase vaccine 
against COVID-19. A test-phase vaccine is likely perceived as less safe 
than an approved vaccine recommended by authorities. 
Table 2 
Responses to vaccination-intention questions in the three current studies.  
Variable Study 1 Study 2 Study 3 
n % n % n % 
COVID-19 vaccine: test-phase       
1 Very unlikely – – 66 34.02 407 30.97 
2 – – 37 19.07 277 17.28 
3 – – 57 29.38 282 21.46 
4 – – 25 12.89 249 18.95 
5 Very likely – – 9 4.64 149 11.34 
COVID-19 vaccine: 
recommended       
1 Very unlikely 14 4.76 8 4.12 159 12.06 
2 26 8.84 15 7.73 55 4.17 
3 41 13.95 20 10.31 143 10.85 
4 75 25.51 49 25.26 288 21.85 
5 Very likely 138 46.94 102 52.58 673 51.06 
Influenza vaccine: 5-point scale       
1 Very unlikely 37 12.59 – – 291 22.59 
2 31 10.54 – – 92 7.14 
3 31 10.54 – – 135 10.48 
4 45 15.31 – – 116 9.01 
5 Very likely 150 51.02 – – 654 50.78 
Influenza vaccine: 3-point scale       
No intention to vaccinate – – 80 40.00 – – 
Undecided – – 63 31.50 – – 
Intend to vaccinate – – 57 28.50 – – 
Note. Study 1: labels for the response alternatives 2 (not that likely), 3 (hard to 
say), and 4 (quite likely) were provided. Study 2: 6 (3.0%) responses missing 
concerning the COVID-19 vaccines. Study 3: 10 (0.8%) responses missing con-
cerning the test-phase COVID-19 vaccine, 6 (0.5%) concerning the recom-
mended COVID-19 vaccine, and 36 (2.7%) concerning the influenza vaccine. 
Table 3 
Zero-order correlations between the measures included in Study 1.  
Variable (year of data collection) 1 2 3 4 
1. Germ aversion (2018) –    
2. Perceived infectability (2018) 0.38 –   
3. COVID-19 vaccination intentions (2020) − 0.03 0.05 –  
4. Influenza vaccination intentions (2020) − 0.01 0.15 0.57 – 
Note. Bolded correlation coefficients p < 0.05. 
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4.1. Respondents and procedure 
In April 2019, we invited 5000 18–65-year-old individuals living in 
the Finnish Pietarsaari region to an online survey on vaccine attitudes. 
The individuals were randomly drawn from the Population Information 
System, which is a national register holding information about all in-
dividuals living in Finland (Digital and Population Data Services 
Agency, 2021). The sample of invitees was stratified according to the 
age, gender, and language distribution (Finnish and Swedish) in the 
region. We targeted the Pietarsaari region because it has a suboptimal 
uptake of several vaccines in the national vaccination program. The 
survey was open for two weeks, and a total of 1139 (22.8%) individuals 
responded. On March 30th, 2020, those 335 (29.4%) who in the data 
collection in 2019 had consented to being contacted again and provided 
their e-mail address were invited to fill out an online survey related to 
the coronavirus pandemic. A total of 205 (61.2%) individuals replied 
and 200 (59.7%) had responded to the questions on germ aversion and 
perceived infectability. The sample is described in Table 1. We 
compared the demographics of the individuals who responded in 2020 
to those of the original sample who did not. The results from these 
analysis can be found in the online supplementary material. 
The Board for Research Ethics at Åbo Akademi University approved 
the study. Respondents gave their informed consent electronically and 
did not receive any compensation for their participation. 
4.2. Measures 
4.2.1. Germ aversion and perceived infectability 
As in Study 1, we measured germ aversion and perceived infect-
ability with the PVD scale (Duncan et al., 2009). 
4.2.2. Vaccination intention 
Concerning a recommended vaccine against COVID-19, we pre-
sented the question: “Imagine a hypothetical scenario where the au-
thorities recommend a new vaccine against COVID-19 free of charge. 
How likely do you consider it to be that you would accept such a vac-
cine?”. Hence, the formulation of the question was slightly different 
from that of Study 1. We additionally measured willingness to take a 
test-phase vaccine against COVID-19 with the question: “Imagine a hy-
pothetical scenario where you would be offered the possibility to 
participate in a trial of a new vaccine against COVID-19 that is under 
development. How likely do you consider it to be that you would accept 
such a vaccine?”. Response alternatives ranged from 1 (very unlikely) to 5 
(very likely). 
To measure intentions to accept the influenza vaccine, we presented 
the question “Will you take the influenza vaccine next season (season 
2020–2021)?” with the response alternatives “no”, “yes”, or “I don’t 
know”. We re-coded the responses as 0 (no intent to vaccinate or un-
decided) or 1 (intend to vaccinate). 
4.3. Statistical analyses 
The statistical procedures were the same as in Study 1 (the mea-
surement model is presented in Appendix Table A3). The reliability of 
the PVD subscales were α = 0.55, 95% CI [0.43, 0.64] for germ aversion 
and α = 0.82, 95% CI [0.77, 0.86] for perceived infectability. The reli-
ability of the germ aversion subscale was thus poor. Nevertheless, 
measurement error was taken into account in the analyses, as the sub-
scales were represented by latent factors. The fit of the measurement 
model was good. 
5. Study 2: results and discussion 
The respondents’ vaccination intentions are presented in Table 2. 
Although the respondents were recruited from an area with sub-optimal 
vaccine uptake, they did not report systematically lower intentions to be 
vaccinated than the other two samples. The sample might thus not be 
representative of the population in the region. Descriptive information 
on the responses to the PVD scale is presented in Table A2. 
The fit of the SR model was good (χ2[109] = 164.05, CFI = 0.963, 
TLI = 0.954, RMSEA = 0.050; 90% CI [0.034, 0.066], SRMR = 0.081). 
The zero-order relationships indicated that higher germ aversion and 
perceived infectability were significantly related to higher intention to 
accept a recommended COVID-19 vaccine and the next influenza vac-
cine (Table 4). In the regression model (Fig. 2; see also, Fig. 5 in the 
Meta-analysis section), where the PVD measures controlled for each 
other, the only statistically significant relationship was between 
perceived infectability and influenza vaccination intention. However, 
also this relationship was non-significant in the analysis controlling for 
gender and age (the strength of the relationship was approximately the 
same but the uncertainty in the estimate was larger; Table S2). 
In contrast to Study 1 (where germ aversion was measured before the 
pandemic), the relationships between germ aversion and vaccination 
intentions in Study 2 (where mid-pandemic germ aversion was 
measured) were positive and slightly stronger, but the relationships did 
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Fig. 1. Germ aversion and perceived infectability (measured in 2018) as predictors of vaccination intentions (measured in 2020) in Study 1. Factor indicators and 
covariance, as well as disturbance covariances between outcomes, are not shown in the figure. *p < 0.05, **p < 0.01, ***p < 0.001. 
Table 4 
Zero-order correlations among measures in Study 2.  
Variable 1 2 3 4 5 
1. Germ aversion –     
2. Perceived infectability 0.60 –    
3. COVID-19 vaccination intentions: 
recommended 
0.24 0.16 –   
4. COVID-19 vaccination intentions: test- 
phase 
0.14 0.11 0.50 –  
5. Influenza vaccination intentions 0.51 0.44 0.53 0.35 – 
Note. Bolded correlations p < 0.05. Because the influenza vaccination measure 
was dichotomous, the estimates related to influenza vaccination intentions are 
represented by zero-order probit regression coefficients. 
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small sample size. 
6. Study 3: method 
Study 3 replicated the analyses from Study 2 in a larger sample. In 
Study 3, we investigated the issue of perceived vaccine safety further by 
asking explicitly about the perceived safety of a recommended COVID- 
19 vaccine and the influenza vaccines. 
6.1. Respondents and procedure 
Between the 3rd and 17th of April 2020 (two weeks), we marketed a 
Facebook post with a link to an online survey including questions related 
to the coronavirus pandemic. The post reached 97,408 Facebook users 
and 2233 (2.3%) started to fill out the questionnaire. We included the 
1325 individuals who completed the questionnaire (i.e., had responded 
to questions on the last page of the survey) and who had answered an 
attention check question correctly. One individual, who had not 
answered any questions related to germ aversion or perceived infect-
ability, was excluded, and the final sample size was 1324. The mean age 
of the sample was 47.71 years (SD = 13.11, range = 18–100, n = 1022; 
see, Table 1 for more information on the sample). 
The Board for Research Ethics at Åbo Akademi University approved 
the study. Respondents gave their informed consent electronically and 
did not receive any compensation for their participation. 
6.2. Measures 
6.2.1. Germ aversion and perceived infectability 
As in Studies 1 and 2, we used the PVD scale (Duncan et al., 2009) to 
measure germ aversion and perceived infectability. 
6.2.2. Perceived vaccine safety 
We measured how safe the respondents perceived a vaccine against 
COVID-19 would be with the statements “If a vaccine against COVID-19 
became part of the recommended vaccines in Finland, I would trust that 
it is safe”. Furthermore, we measured the perceived safety of the influ-
enza vaccines with the statement “The influenza vaccines are safe”. 
Respondents indicated whether they agree on a scale from 1 (completely 
disagree) to 5 (completely agree). 
6.2.3. Vaccination intentions 
We measured intentions to accept a recommended vaccine and a test- 
phase vaccine against COVID-19 with the same questions as in Study 2. 
Intentions to accept the influenza vaccine the next season was measured 
in the same way as in Study 1. 
6.3. Statistical analyses 
The reliability of the PVD scale was α = 0.67, 95% CI [0.63, 71] for 
germ aversion and α = 0.82, 95% CI [0.80, 84] for perceived infect-
ability. The statistical procedure was the same as in Studies 1 and 2 (the 
measurement model is shown in Appendix Table A4). Additionally, we 
analyzed a second model with the perceived safety of a recommended 
COVID-19 vaccine and the influenza vaccines as outcomes. 
7. Study 3: results and discussion 
Table 2 shows the responses to the variables measuring vaccination 
intentions. The responses to the PVD scale are presented in Table A2. All 
zero-order correlations between the PVD measures and the vaccine 
related variables were statistically significant and positive (Table 5). 
The fit of the SR model on vaccination intentions was satisfactory 
(χ2[108] = 537.96, CFI = 0.960, TLI = 0.950, RMSEA = 0.055; 90% CI 
[0.050, 0.060], SRMR = 0.047), as was the fit of the vaccine safety 
model (χ2[96] = 549.15, CFI = 0.958, TLI = 0.948, RMSEA = 0.060; 
90% CI [0.055, 0.065], SRMR = 0.051). Germ aversion was significantly 
related to intentions to accept a recommended COVID-19 vaccine and 
the influenza vaccine (Fig. 3; see also Fig. 5 in the Meta-analysis sec-
tion). The relationships were in the opposite direction of what was hy-
pothesized based on previous studies, as those with more germ aversion 
had higher intentions to vaccinate. Individuals with more germ aversion 
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Fig. 2. Germ aversion and perceived infectability as predictors of vaccination intentions in Study 2. Factor indicators and covariance, as well as disturbance co-
variances between outcomes, are not shown in the figure. *p < 0.05, **p < 0.01, ***p < 0.001. 
Table 5 
Zero-order correlations between measures in Study 3.  
Variable 1 2 3 4 5 6 7 
1. Germ aversion –       
2. Perceived infectability 0.66 –      
3. COVID-19 vaccination 
intentions: 
recommended 
0.38 0.43 –     
4. COVID-19 vaccination 
intentions: test-phase 
0.16 0.22 0.61 –    
5. Influenza vaccination 
intentions 
0.37 0.43 0.61 0.46 –   
6. Perceived safety: COVID- 
19 vaccine 
0.33 0.37 0.81 0.58 0.59 –  
7. Perceived safety: 
influenza vaccine 
0.28 0.32 0.66 0.49 0.63 0.74 – 
Note. Bolded correlations p < 0.05. 
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with less germ aversion (Fig. 4). There was no relationship between 
germ aversion and willingness to take a test-phase vaccine. Potentially, 
higher uncertainty concerning the safety of such a vaccine leads more 
individuals—not only those high on germ aversion—to decline vacci-
nation. The same logic could explain why germ aversion was unrelated 
to perception regarding the safety of influenza vaccines. The perceived 
safety of the influenza vaccines has been found to be lower than that of 
other vaccines (Karlsson et al., 2021). This might be because the Pan-
demrix vaccine administered against the H1N1 influenza during the 
pandemic in 2009–2010 was later found to increase the risk of narco-
lepsy (Sarkanen, Alakuijala, Julkunen, & Partinen, 2018). The associa-
tion between the vaccine and narcolepsy was frequently covered by 
Finnish media. This event might have caused more widespread concerns 
about the safety of influenza vaccines, not only among those with higher 
germ aversion. 
For perceived infectability, the SR results on influenza from Studies 1 
and 2 were replicated, as individuals with higher perceived infectability 
reported higher intent to take the influenza vaccine the upcoming sea-
son. Contrary to Studies 1 and 2, perceived infectability was also 
significantly related to willingness to accept COVID-19 vaccination. 
Perceived infectability was more strongly related to vaccination in-
tentions than germ aversion was (confidence intervals not overlapping). 
Those with higher perceived infectability also reported significantly 
greater trust in the safety of the vaccines. 
The control analyses produced roughly the same results (Table S3). 
Some of the relationships were slightly weaker and uncertainty in the 
estimates was larger when gender and age were included in the models. 
Because the relationships were small to begin with, some became non- 
significant in the control model. Nevertheless, the general conclusion, 
that the associations including germ aversion were in the opposite of 
what was hypothesized, and that higher perceived infectability was 
related to higher vaccination intentions, did not change when control-
ling for gender and age. 
8. Meta-analysis 
To receive an estimate of the overall size of the relationships between 
the behavioral immune system components and vaccination intentions, 
we combined the effect sizes obtained across studies and vaccines. We 
conducted separate meta-analyses for germ aversion and perceived 
infectability (the effect sizes we combined were still retrieved from the 
models where germ aversion and perceived infectability were simulta-
neously included). We also conducted separate meta-analyses for the 
pre- and mid-pandemic measures. Hence, the effect sizes concerning pre- 
pandemic PVD included only Study 1, whereas the effect sizes related to 
mid-pandemic PVD included Studies 2 and 3. To account for dependency 
between measures obtained from the same participants, we applied a 
mixed-effects model. The β coefficients were treated as r coefficients, 
and z-transformed to obtain linearity. The results were transformed back 
to r coefficients and interpreted as β coefficients. 
The results from the meta-analyses are shown in Fig. 5. There was no 
significant relationship between pre-pandemic germ aversion and 
vaccination intentions (β = − 0.07, 95% CI [− 0.15, 0.01], p = 0.091), 
whereas those with higher pre-pandemic perceived infectability had 
slightly higher intentions to accept vaccines (β = 0.12, 95% CI [0.04, 
0.20], p = 0.004). The relationships between the mid-pandemic PVD 
measures and vaccination intentions were weak but statistically signif-
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Fig. 3. Germ aversion and perceived infectability as predictors of vaccination intentions in Study 3. Factor indicators and covariance, as well as disturbance co-
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Fig. 4. Germ aversion and perceived infectability as predictors of perceived vaccine safety in Study 3. Factor indicators and covariance, as well as disturbance 
covariances between outcomes, are not shown in the figure. *p < 0.05, **p < 0.01, ***p < 0.001. 
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[0.15, 0.41], p ≤0.001, for germ aversion and perceived infectability, 
respectively). Individuals who reported higher germ aversion and 
perceived infectability during the pandemic had higher intentions to 
accept vaccines. 
9. General discussion 
In the present study, we investigated if individual differences in as-
pects of the behavioral immune system (germ aversion and perceived 
infectability) can explain people’s intentions to vaccinate against 
COVID-19 and their trust in the safety of the vaccine. Based on previous 
research (Clay, 2017; Clifford & Wendell, 2016; Hornsey et al., 2018a; 
Luz et al., 2019; Reuben et al., 2020), we hypothesized that higher germ 
aversion would be related to hesitancy to accept COVID-19 vaccination 
and believing the vaccine to be unsafe. We further hypothesized that 
higher perceived infectability would be related to higher willingness to 
accept COVID-19 vaccination. We also measured the respondents’ in-
tentions to accept influenza vaccination in the upcoming influenza 
season. 
9.1. Germ aversion 
Contrary to our hypotheses, the combined results of the three studies 
indicated that individuals with more germ aversion did not report lower 
intentions to accept vaccines (Fig. 5). Instead, the results indicated that 
pre-pandemic germ aversion was unrelated to vaccination intentions 
during the pandemic, whereas those with more mid-pandemic germ 
aversion had slightly higher intentions to vaccinate. This relationship 
was, however, weak. Previous research has focused primarily on atti-
tudes to vaccines (i.e., the safety and efficacy of vaccines) and found 
higher pathogen disgust sensitivity and germ aversion to be associated 
with more negative attitudes (Clay, 2017; Clifford & Wendell, 2016; Luz 
et al., 2019; Reuben et al., 2020). These findings have been interpreted 
as the behavioral immune system reacting to vaccination as a cue to 
contamination, leading to an aversive response to vaccines. Our results 
indicated that those with more germ aversion during the pandemic 
perceived vaccines as slightly safer, and they were not less willing to 
accept a test-phase COVID-19 vaccine—a vaccine likely perceived as less 
safe—compared to those with less germ aversion. These results do not 
support the notion that individuals respond to vaccination as a cue to 
contamination. 
One possible explanation for our finding is, of course, that vaccina-
tion is not recognized as a contamination cue. This explanation is, 
however, in contradiction with previous results. An alternative expla-
nation could be that the increased disease threat at the time of data 
collection overrides an aversive response to vaccines as contamination, 
and that this is particularly true for those with high germ aversion. For 
individuals with high germ aversion, the perceived pathogen threat 
posed by vaccines might pale in comparison to that posed by COVID-19. 
This is in line with the assumption that the behavioral immune system 
response should be heightened in situations that pose increased disease 
threat. More specifically, the results would indicate that the effect of 
individual differences in the behavioral immune system are moderated 
by situational factors such as level of threat. It is noteworthy that mid- 
pandemic germ aversion was positively related also to intentions to 
accept influenza vaccination, indicating that the effect of increased 
disease threat is generalized across vaccines and not only affects the 
vaccine preventing the disease that poses the current treat. As the pre-
sent study did not examine the relationship between germ aversion and 
vaccination during lower threat circumstances, this explanation is, 
however, highly hypothetical. 
9.2. Perceived infectability 
The combined results of the three studies suggested that individuals 
with higher perceived infectability had higher vaccination intentions 
(Fig. 5). Although the relationships were weak, the results are in line 
with the theory of the behavioral immune system. When individuals 
perceive themselves as more vulnerable, they are expected to be more 
motivated to take preventive action. Interestingly, those with higher 
perceived infectability perceived the vaccines as safer. This indicates 
that perceived infectability is related not only to vaccination intentions 
but to perceptions of the vaccines. 
There was, however, variation between the studies in the strength of 
Fig. 5. Standardized beta coefficients for the relationships between the PVD measures (germ aversion and perceived infectability) and intentions to accept a rec-
ommended COVID-19 vaccine and influenza vaccines in all three studies. 
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the relationships, with perceived infectability showing the most 
consistent relationship with intention to accept influenza vaccination. 
Previous research has found higher perceived infectability to be related 
to having accepted past influenza vaccination (Luz et al., 2019), but 
unrelated to attitudes towards childhood vaccines and vaccines in gen-
eral (Clay, 2017; Luz et al., 2019). Potentially, perceived infectability is 
more robustly related to influenza vaccination intentions, as the PVD 
subscale mainly probes the respondents’ history of catching infectious 
diseases. Relative to influenza, few individuals in Finland have been 
infected with COVID-19 (Finnish Institute for Health and Welfare, 2020, 
2021a), and responses may, therefore, to a greater degree be based on 
respondents’ history of catching influenza or influenza-like illnesses. 
9.3. Study limitations and recommendations for future research 
All data in the present study were based on self-reports. Self-reports 
are vulnerable to biases related to, for example, social desirability. To 
decrease the risk that social desirability would affect the responses, all 
respondents were informed that the data would be handled without 
identifying information. Also, the responses relating to the mid- 
pandemic period, and especially those relating to germ aversion, 
might have been affected by compliance with the official recommen-
dations concerning protective behaviors during the time of the data 
collection, and might not have been solely based on heightened levels of 
aversion. The reliability of the germ aversion subscale, represented by 
Cronbach’s alpha, was low in the three samples (α = 0.68, α = 0.55, and 
α = 0.67, respectively). Speculatively, this could be related to issues 
with translation or to the pandemic context (other studies measuring 
germ aversion during the pandemic has received α estimates around 
0.70; De Coninck et al., 2020; Makhanova & Shepherd, 2020; Shook 
et al., 2020). Nevertheless, latent variables were used in the analyses to 
mitigate the influence of measurement error on the results. 
The fact that two of the samples were relatively small leads to large 
uncertainty in the estimates. Furthermore, there are sample-specific 
limitations to the generalizability of the results. First, the respondents 
in the sample of Study 1 are participating in a longitudinal study that 
includes multiple health-related surveys and medical examinations over 
several years. It is possible that these respondents hold more positive 
attitudes to medical treatments, including vaccination, compared to the 
general population. Second, according to national statistics, the Pie-
tarsaari region has a lower uptake of childhood vaccines compared to 
other Finnish regions. The sample recruited from this region in Study 2, 
however, did not systematically report lower willingness to accept 
vaccines than the other two samples. The Pietarsaari sample might thus 
not be representative of the region. This might be a result of the 
recruitment process, and that those who had consented to being con-
tacted again held more positive vaccine attitudes than those who did 
not. Third, self-selection bias might be especially relevant for Study 3. 
Whereas the respondents in Studies 1 and 2 received personal invitations 
to the surveys, the sample in Study 3 entered the survey by clicking an ad 
in their Facebook feed. Individuals who chose to interact with the ad 
might differ from those who did not. For example, those responding 
might have more extreme attitudes to vaccines. 
The fact that the current studies were conducted during and directly 
after the first pandemic peak can be considered both a strength and a 
limitation. The strength lies in the fact that we had a unique opportunity 
to investigate behavioral immune system mechanisms during higher 
disease threat. However, the questions about COVID-19 vaccination 
were highly hypothetical, and there was large uncertainty regarding if 
and when such vaccines could be available. Knowledge about the virus 
was also limited. The vaccination intentions that individuals report in 
such circumstances might be very different from their actual vaccination 
behaviors when they are offered a vaccine. 
Our speculation, that the increased disease threat explains why our 
results differed from those obtained in previous research, should be 
investigated in future studies. Our study also differs from previous 
research in other ways. For example, we mainly investigated in-
dividuals’ intentions to vaccinate themselves, whereas previous 
research has investigated attitudes to vaccines (except for Luz et al., 
2019 that investigated past influenza vaccination behavior). Further-
more, none of the previous studies investigated attitudes or intentions 
related to COVID-19 vaccines. Nevertheless, we find it unlikely that 
these differences between studies cause the opposing results. 
9.4. Conclusions 
In the current study, individuals with high germ aversion were not 
more likely to react to vaccination as a contamination cue. Instead, the 
combined results of the studies suggested that those with higher germ 
aversion during the pandemic were slightly more willing to accept 
vaccines, and, thus, to protect themselves against disease. Level of germ 
aversion before the pandemic did not predict vaccination intentions. It is 
possible that current high disease threat moderates the relationship 
between behavioral immune system response and vaccination. When it 
comes to perceived infectability, the results were in line with the theory 
of the behavioral immune system and suggested that individuals 
perceiving themselves as more susceptible to diseases were slightly more 
willing to accept vaccination. 
In sum, the results of the present study indicated that behavioral 
immune system activation promotes acceptance of vaccines when dis-
ease threat is high, but the associations were weak and of little practical 
relevance for public campaigns aimed at increasing vaccine uptake. 
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Appendix A  
Table A1 
Factor loadings and variances from the measurement model in Study 1.  
Factor Unstandardized Standardized 
Parameter Estimate SE Estimate SE R2 
Factor loadings 
Germ aversion Item 1  1.00 − 0.57 0.06 0.33 
Item 3  1.17 0.15 0.67 0.04 0.45 
Item 4  0.92 0.13 0.53 0.05 0.28 
Item 7  1.27 0.17 0.73 0.05 0.53 
Item 9  0.46 0.14 0.27 0.08 0.07 
Item 11  0.72 0.14 0.41 0.07 0.17 
Item 13  0.87 0.14 0.50 0.06 0.25 
Perceived infectability Item 2  1.00 – 0.74 0.02 0.55 
Item 5  0.75 0.06 0.55 0.04 0.31 
Item 6  1.16 0.05 0.86 0.02 0.74 
Item 8  1.31 0.05 0.97 0.01 0.95 
Item 10  0.91 0.04 0.67 0.03 0.45 
Item 12  0.71 0.07 0.53 0.05 0.28 
Item 14  0.65 0.07 0.48 0.05 0.23  
Factor variances 
Germ aversion   0.33 0.07 – – – 
Perceived infectability   0.55 0.03 – – – 
Note. Model fit: χ2(73) = 111.46, CFI = 0.991, TLI = 0.988, RMSEA = 0.042; 90% CI [0.025, 0.058], SRMR = 0.061. Residual correlations between the reversed items 
of Perceived infectability were included (Item 5 and Item 2: r = 0.45, p < 0.001; Item 12 and Item 14: r = 0.35, p < 0.001; Item 5 and Item 14: r = 0.38, p < 0.001).  
Table A2 
Responses to perceived vulnerability to disease in all studies.   
Study 1 (2018) Study 2 (2020) Study 3 (2020) 
M SD M SD M SD 
Germ aversion       
Item 1  5.64  1.60  6.54  1.02  6.64  1.05 
Item 3a  4.49  2.02  2.16  1.76  1.67  1.56 
Item 4  3.54  1.89  5.89  1.77  6.03  1.89 
Item 7  3.40  1.81  6.15  1.34  6.38  1.43 
Item 9  2.22  1.59  3.65  2.37  4.04  2.43 
Item 11a  3.41  1.98  2.98  2.23  2.53  2.15 
Item 13a  4.81  1.60  3.50  2.07  2.69  2.17 
Perceived infectability       
Item 2  2.90  1.41  4.43  1.39  4.34  1.62 
Item 5a  4.30  1.62  2.99  1.83  3.30  2.05 
Item 6  2.99  1.61  2.93  1.82  3.84  1.83 
Item 8  2.98  1.58  3.38  1.75  3.94  1.92 
Item 10  2.40  1.57  2.66  1.71  3.77  2.01 
Item 12a  4.06  1.60  2.92  1.76  2.94  1.84 
Item 14a  4.18  1.54  3.07  1.63  2.67  1.79  
a Reverse-scored item.  
Table A3 
Factor loadings and variances from the measurement model in Study 2.  
Factor Unstandardized Standardized 
Parameter Estimate SE Estimate SE R2 
Factor loadings 
Germ aversion Item 1  1.00 − 0.77 0.11 0.59 
Item 3  0.55 0.17 0.42 0.12 0.18 
Item 4  0.80 0.15 0.62 0.11 0.38 
Item 7  0.80 0.15 0.62 0.09 0.38 
Item 9  0.55 0.13 0.43 0.07 0.18 
Item 11  0.54 0.16 0.42 0.11 0.18 
Item 13  0.48 0.21 0.37 0.15 0.14 
Perceived infectability Item 2  1.00 – 0.64 0.04 0.40 
Item 5  0.60 0.15 0.38 0.10 0.15 
Item 6  1.39 0.10 0.88 0.03 0.78 
Item 8  1.40 0.10 0.89 0.03 0.79 
Item 10  1.13 0.09 0.72 0.04 0.52 
Item 12  0.77 0.11 0.49 0.06 0.24 
Item 14  0.77 0.09 0.49 0.05 0.24  
(continued on next page) 
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Table A3 (continued ) 
Factor Unstandardized Standardized 
Parameter Estimate SE Estimate SE R2 
Factor variances 
Germ aversion   0.59 0.17 – – – 
Perceived infectability   0.40 0.05 – – – 
Note. Model fit: χ2(73) = 121.97, CFI = 0.967, TLI = 0.958, RMSEA = 0.058; 90% CI [0.039, 0.076], SRMR = 0.083. The model included residual correlations between 
the reversed items of Perceived infectability (Item 5 and Item 12: r = 0.62, p < 0.001; Item 5 and Item 14: r = 0.45, p < 0.001; Item 12 and Item 14: r = 0.44, p < 0.001).  
Table A4 
Factor loadings and variances from the measurement model in Study 3.  
Factor Unstandardized Standardized 
Parameter Estimate SE Estimate SE R2 
Factor loadings 
Germ aversion Item 1  1.00 − 0.67 0.05 0.45 
Item 3  1.05 0.09 0.70 0.04 0.49 
Item 4  0.88 0.08 0.59 0.04 0.35 
Item 7  1.27 0.09 0.85 0.03 0.72 
Item 9  0.81 0.07 0.54 0.03 0.30 
Item 11  0.71 0.08 0.47 0.04 0.23 
Item 13  1.01 0.09 0.67 0.04 0.45 
Perceived infectability Item 2  1.00 – 0.79 0.02 0.63 
Item 5  0.54 0.05 0.43 0.04 0.18 
Item 6  0.87 0.04 0.69 0.02 0.47 
Item 8  0.94 0.04 0.74 0.02 0.55 
Item 10  0.72 0.04 0.57 0.02 0.33 
Item 12  0.79 0.04 0.63 0.03 0.40 
Item 14  0.94 0.04 0.74 0.02 0.55  
Factor variances 
Germ aversion   0.45 0.06 – – – 
Perceived infectability   0.63 0.04 – – – 
Note. Model fit: χ2(72) = 458.30, CFI = 0.966, TLI = 0.957, RMSEA = 0.064; 90% CI [0.058, 0.069], SRMR = 0.053. The model included residual correlations between 
Item 6 and Item 8: r = 0.60, p < 0.001; Item 8 and Item 10: r = 0.36, p < 0.001; Item 6 and Item 10: r = 0.31, p < 0.001; and Item 5 and 12: r = 0.32, p < 0.001. 
Appendix B. Supplementary data 
Supplementary data to this article can be found online at https://doi.org/10.1016/j.paid.2021.111295. 
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